Showing results (1-10 of 212) with videos related to
Sort By:
Pageof 22
Current Opinion in Immunology|January 22, 2004
Proteasome and peptidase function in MHC-class-I-mediated antigen presentationPeter Michael Kloetzel, Ferry OssendorpMethods in Molecular Biology (Clifton, N.J.)|May 3, 2022
Measuring the Antitumor T-Cell Response in the Context of Photodynamic TherapyJan Willem Kleinovink, Ferry OssendorpMethods in Molecular Biology (Clifton, N.J.)|May 3, 2022
Combination of Photodynamic Therapy and Therapeutic VaccinationJan Willem Kleinovink, Ferry OssendorpMethods in Molecular Biology (Clifton, N.J.)|May 3, 2022
Combination of Photodynamic Therapy and Immune Checkpoint BlockadeJan Willem Kleinovink, Ferry OssendorpInternational Journal of Molecular Sciences|September 10, 2021
Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the SpotlightsMarieke F Fransen, Thorbald van Hall, Ferry OssendorpJournal of Visualized Experiments : Jove|December 31, 2019
Visualization and Quantification of High-Dimensional Cytometry Data using Cytofast and the Upstream Clustering Methods FlowSOM and CytosploreGuillaume Beyrend, Koen Stam, Ferry Ossendorp, et al.Advances in Immunology|December 2, 2023
How B cells drive T-cell responses: A key role for cross-presentation of antibody-targeted antigensFerry Ossendorp, Nataschja I Ho, Nadine Van MontfoortCellular and Molecular Life Sciences : CMLS|February 22, 2012
The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentationFrédéric Ebstein, Andrea Lehmann, Peter-Michael KloetzelMolecular Immunology|January 6, 2023
ERAP2 supports TCR recognition of three immunotherapy targeted tumor epitopesKarin Schmidt, Matthias Leisegang, Peter-Michael KloetzelPharmaceutics|April 30, 2021
Cationic Nanoparticle-Based Cancer VaccinesJeroen Heuts, Wim Jiskoot, Ferry Ossendorp, et al.Pageof 22